CrossrefInfokarte
A Prospective Multicenter Assessment of the Accuracy and Safety of the Yuwell CT3 Real‐Time Continuous Glucose Monitoring System in Patients With Diabetes Over 14 Days
Journal of Diabetes · 2026-07 · 18 (7)
DOI: 10.1111/1753-0407.70246 ↗Abstract
Highlights This 14‐day multicenter study assessed CT3 CGM accuracy and safety in 71 adults with diabetes. Key results: overall MARD 9.1% (median 7.1%), 82.4%–98.2% met %15/15–%30/30 criteria, 99.7% values in CEG zones A/B. CT3 showed strong performance, suitable for reliable 14‐day wear.
EUVIMED